Skip to content

NeuroCentury

Active Private limited companyfounded 2023active for 3 yearsFranklin Rooseveltlaan 256, 1050 BrusselsKBO/BCE: BE 0805.251.042

Lifetime

2 annual accounts with figures on one time axis
peak of €118,465 in 2025
€118,465▲ 47.0%
peak of €90,329 in 2025
€90,329▲ 53.5%
peak of €154,162 in 2025
€154,162▲ 142%
€96,431▲ 116%
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from €80,602 to €118,465Result from €58,833 to €90,329Equity from €63,833 to €154,162Debts from €44,593 to €96,431Cash from €52,868 to €89,376

Key points

from the 2025 annual accounts

Equity

€154,162 ▲ 142%
€63,8002024€154,0002025

Equity rose in 2025 from €63,833 to €154,162.

Debts

€96,431 ▲ 116%
Suppliers
+26,585
Taxes and wages
+25,253

Debts rose by €51,838 in 2025.

Position in the sector

€90,329

Higher net result than 89% of companies in advertising and market research. The sector median is €14,082, over 9,141 companies.

2025 accounts filed 24 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as NeuroCentury has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for NeuroCentury. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 30-08-2023
Director, since 01-01-2024
  • 100 sharesdeed of 01-09-2023
  • 100 sharesdeed of 01-09-2023
Board & ownership

Recent changes

appointed as director General meeting of 01-01-2024 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0805251042
Incorporation Founding capital of €5,000, 200 shares · Founded by and · appointed as director · published on 01-09-2023 · Gazette deed
All 7 events

Comparable companies

same main activity, similar in size and age
Company
NeuroCentury Brussels €250,594 €118,465 61.5% -
APRICITAS Ixelles €225,513 €118,216 81.6% -
LA DALLE CREATIVE Schaerbeek €230,883 €118,723 76.7% -
Broadview Public Affairs Auderghem €254,735 €115,576 76.1% -
Babeda Uccle €284,057 €122,751 89.1% -
HELIME Mouscron €248,345 €116,483 24.4% -
Devisch Consulting Haacht €258,350 €118,375 75.9% -

These companies have the same main activity as NeuroCentury: public relations and communication consultancy (NACE 73300). They are comparable in size and age: total assets between €226,000 and €284,000, founded in 2023.

Official details

Source: KBO
Status
Active since 30-08-2023Normal situation
Activity
Public relations and communication consultancyNACE 73300and 3 others
Establishment unit
2.351.327.4111050 Brussels, since 30-08-2023
Financial year end
31 December
Peppol
Reachable since 30-10-2023
Company details

Annual accounts 2025

≈ €220,000estimated
€250,594▲ 131%
Filing
Filed on 24-08-2026
Financials

Insights on NeuroCentury

NeuroCentury has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €154,162 and a net result of €90,329.

Its solvency ranks better than 57% of 9,140 sector peers (NACE 73) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NeuroCentury

What is the company number of NeuroCentury?
The company number of NeuroCentury is 0805.251.042. The VAT number is the same number with BE in front: BE 0805.251.042.
Where is NeuroCentury based?
The registered office is at Franklin Rooseveltlaan 256, 1050 Brussels.Company details
What does NeuroCentury do?
According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
What is the legal form of NeuroCentury?
NeuroCentury is a private limited company (BV).
When was NeuroCentury founded?
NeuroCentury was founded on 30-08-2023.
Is NeuroCentury still active?
Yes, NeuroCentury is an active enterprise in the KBO register.
What is the turnover of NeuroCentury?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €118,465 and 38 comparable companies (NACE 73). It probably lies between €160,000 and €430,000.Financials
Is NeuroCentury profitable?
In financial year 2025, NeuroCentury made a profit of €90,329.
Where can I find the annual accounts of NeuroCentury?
NeuroCentury filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NeuroCentury due?
NeuroCentury must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.